The merger, which has brought about a new entity–Dannex Ayrton Starwin–has been approved by the Ghana Stock Exchange.
Shareholders of the Ayrton Drugs and Starwin Products Limited at their separate extraordinary general meetings held on December 27, 2018 agreed to the scheme of amalgamation while in the case of Dannex Plc, its shareholders endorsed the deal on January 30, last year. This was after the High Court of Justice (Commercial Division) had also given its consent on November 25, 2019.
The register of members of Ayrton Drugs Manufacturing Limited and Starwin Products Limited will hence be closed to the general public on Thursday, January 9, with today as the qualifying date.
Dannex, which made this known recently, said, “Only shareholders on the register of members of Ayrton Drugs Manufacturing Limited and Starwin Products Limited at the close of business on Wednesday, January 8, 2020 will, therefore, be entitled to receive Dannex Ayrton Starwin Plc shares under the scheme.”
UMB Investment Holdings Limited and UMB Stockbrokers are the financial advisors and sponsoring brokers to the transaction.